About 53% of the public is in favor of Congress’ taking action to cap the out-of-pocket cost of insulin, according to a recent poll from the Kaiser Family Foundation.
pay more than $35 per month — or $420 a year — for the lifesaving medication. Patients usually need to buy multiple vials a month to maintain their health, which can sometimes cause costs to skyrocket.
Senate Majority Leader Charles Schumer, D-N.Y., vowed to bring the measure back up for a vote this fall.on Monday. “We’re going to come back and make them vote on that again." “Some ideas take years to make their way into law but get there,” said Tricia Neuman, a Medicare expert with the Kaiser Family Foundation. Neumanpublished last month that detailed how the Senate's reconciliation bill could affect both people on Medicare and people on private insurance.
McCook works as a veterinarian, and he is able to get his daughter insulin through his employee health insurance, but not before he shells out the $6,000 a year his plan requires before his insurance begins to pay.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Willow Smith Shares Why Aftermath of Will Smith's Oscars Slap Didn't 'Rock' HerFour months after Will Smith slapped Chris Rock at the 2022 Oscars for making a joke about Jada Pinkett Smith's shaved head, Willow Smith is addressing the media frenzy around the drama.
Baca lebih lajut »
Senate Republicans block $35 cap on price of insulin from Democratic billSenate Republicans on Sunday blocked a $35 monthly cap on the cost of insulin in the private market from being included in Democrats' economic tax and spending package.
Baca lebih lajut »
Senate Republicans derail insulin price cap for many consumersDemocrats needed 10 Republican votes to create a price cap on consumers' insulin costs. They ended up three GOP votes short.
Baca lebih lajut »
Republicans blasted for voting down insulin cap after lamenting high pricesRepublican senators who voted against a $35 insulin price cap for private insurers faced criticism for their votes on Monday.
Baca lebih lajut »